INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled drug shows promise for lung scarring and heart strain
Disease control OngoingThis study tests an inhaled medicine called mosliciguat for people with high blood pressure in the lungs caused by scarring lung disease. About 135 adults will receive either the drug or a placebo for 16 weeks. The goal is to see if the drug improves blood flow in the lungs and w…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 26, 2026 07:39 UTC
-
New hope for lung cancer patients with lung scarring: precision radiation trial shows promise
Disease control OngoingThis study tests a precise, high-dose radiation treatment (SABR) for people with early-stage non-small cell lung cancer who also have interstitial lung disease (ILD), a condition that causes lung scarring. About 39 participants will be grouped by ILD severity to see how well the …
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated May 26, 2026 07:32 UTC
-
New drug shows promise for scleroderma lung disease
Disease control OngoingThis study tests a new drug, tulisokibart, for people with scleroderma that has caused lung scarring (interstitial lung disease). The goal is to see if the drug can slow lung damage and improve breathing. About 154 adults with early-stage disease will receive either the drug or a…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 26, 2026 07:32 UTC
-
New inhaled powder shows promise for Lung-Related high blood pressure
Disease control OngoingThis study is testing the safety of an inhaled dry powder drug called LIQ861 (treprostinil) in 80 adults with pulmonary hypertension (high blood pressure in the lungs) linked to lung disease or other causes. Participants receive the drug through an inhaler, and researchers monito…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated May 26, 2026 07:21 UTC
-
Inhaled drug shows promise for Long-Term lung scarring control
Disease control ENROLLING_BY_INVITATIONThis study is for people with lung scarring (idiopathic pulmonary fibrosis or progressive pulmonary fibrosis) who have already been in a related study. It tests the long-term safety of an inhaled medication called treprostinil. The goal is to see if the drug is safe and tolerable…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New CT tool aims to sharpen diagnosis of scarred lungs
Diagnosis OngoingThis study aims to create and test a tool that uses chest CT scans to help doctors more accurately diagnose different types of pulmonary fibrosis, a condition where lung tissue becomes scarred. Researchers will analyze CT scans from 400 adults to identify patterns linked to speci…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Columbia University • Aim: Diagnosis
Last updated May 18, 2026 12:12 UTC
-
New screening method aims to catch hidden Heart-Lung condition early
Diagnosis OngoingThis study tests whether special screening methods can find pulmonary hypertension (high blood pressure in the lungs) earlier in people with interstitial lung disease. About 300 adults with various types of ILD will be screened using heart catheterization to confirm the condition…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: United Therapeutics • Aim: Diagnosis
Last updated May 07, 2026 18:41 UTC
-
9/11 Workers' lungs under the microscope: new study seeks answers
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at lung health in over 2,000 people who worked at the World Trade Center site after 9/11. Researchers will review chest CT scans and breathing tests to find links between their exposures and lung diseases like asthma, COPD, and scarring. The goal is to better und…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 26, 2026 07:22 UTC
-
Firefighter cancer screening study pulled before it began
Knowledge-focused TerminatedThis study planned to give low-dose CT scans to firefighters aged 35 and older to check for lung cancer and other lung diseases caused by job-related smoke and chemical exposure. It aimed to see if screening based on occupation, not just smoking history, could catch cancers earli…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC